Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Biomaterials. 2009 Oct 6;31(3):420–427. doi: 10.1016/j.biomaterials.2009.09.062

Fig. 3.

Fig. 3

Normoglycemic recovery following cPEG adhesive-mediated minimal islet transplantation. (a) Mean non-fasting blood glucose from day 0 (day of transplantation) to day 118 (day of euthanasia), in mice that received 150 islets at the sutured epididymal fat pad (▲, n=7); at the epididymal fat pad with adhesive immobilization (□, n=8); via intrahepatic portal delivery (x, n=7); and at the liver surface with adhesive immobilization (○, n=9). Normoglycemia is defined as non-fasting blood glucose < 200 mg/dL (dotted line). Error bars represent standard error of the mean. (b) Percentage of diabetic recipients remaining within each group as a function of time, following 150-islet transplantation at the sutured epididymal fat pad (solid fine line), at the epididymal fat pad with adhesive immobilization (short dashed line), via intrahepatic portal delivery (solid bold line), and at the liver surface with adhesive immobilization (long dashed line). Asterisk (*) indicates statistical significance in the mean number of days to cure (with n=8) compared to all other groups (p < 0.001).